| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11061606 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 725 journal articles in the PubMed database | Email to a friend | | |
| Ricci S, Antonuzzo A, Galli L, et al.
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Ann Oncol 2000 Sep; 11(9):1127-30.
Abstract | Full Citation | Find Related Articles | | Ricci S, Antonuzzo A, Galli L, et al.
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Am J Clin Oncol 2000 Aug; 23(4):412-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eriksson B, Renstrup J, Imam H, et al.
High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Ann Oncol 1997 Oct; 8(10):1041-4.
Abstract | Full Citation | Find Related Articles | | Bajetta E, Catena L, Procopio G, et al.
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? [Journal Article, Multicenter Study]
Ann Oncol 2005 Aug; 16(8):1374-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Shojamanesh H, Gibril F, Louie A, et al.
Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. [Journal Article]
Cancer 2002 Jan 15; 94(2):331-43.
Abstract | Full Citation | Find Related Articles | | Wymenga AN, Eriksson B, Salmela PI, et al.
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study]
J Clin Oncol 1999 Apr; 17(4):1111.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tomassetti P, Migliori M, Gullo L
Slow-release lanreotide treatment in endocrine gastrointestinal tumors. [Journal Article]
Am J Gastroenterol 1998 Sep; 93(9):1468-71.
Abstract | Full Citation | Find Related Articles | | Raderer M, Kurtaran A, Scheithauer W, et al.
Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid. [Case Reports, Journal Article]
Oncology 2001; 60(2):141-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tomassetti P, Migliori M, Corinaldesi R, et al.
Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. [Journal Article]
Aliment Pharmacol Ther 2000 May; 14(5):557-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
